市場調査レポート
商品コード
1177444

ジェネリック医薬品の世界市場 2023-2027

Global Generic drugs Market 2023-2027

出版日: | 発行: TechNavio | ページ情報: 英文 167 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
ジェネリック医薬品の世界市場 2023-2027
出版日: 2022年12月12日
発行: TechNavio
ページ情報: 英文 167 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートではジェネリック医薬品の市場規模は、2023年から2027年の間に1,762億5,000万米ドル、予測期間中のCAGRは7.11%で成長すると予測しています。

当レポートでは、ジェネリック医薬品市場の全体的な分析、市場規模と予測、動向、成長促進要因・課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。

現在の世界の市場動向と促進要因、市場全体の環境に関する最新の分析を提供しています。市場は、低コストの代替品、創薬および開発のアウトソーシングの増加、医薬品の特許失効の増加によって牽引されています。

本調査では、RPAの登場が今後数年間のジェネリック医薬品市場の成長を促進する主要な理由の1つであると位置付けています。また、M&Aや病院が所有するジェネリック医薬品の増加も、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2022
  • 市場の見通し:2022-2027年の予測

第4章 市場規模実績

  • ジェネリック医薬品の世界市場2017~2021年
  • タイプセグメント分析2017-2021
  • 投与経路セグメント分析2017-2021
  • 地域セグメント分析2017-2021
  • 国セグメント分析2017-2021

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 タイプ別の市場セグメンテーション

  • 市場内訳
  • タイプ別比較
  • 低分子ジェネリック - 市場規模と予測 2022-2027
  • バイオシミラー - 市場規模と予測 2022-2027
  • タイプ別の市場機会

第7章 管理経路別市場セグメンテーション

  • 市場内訳
  • 投与経路別比較
  • 経口 - 市場規模と予測 2022-2027
  • 注射剤 - 市場規模と予測 2022-2027
  • トピック - 市場規模と予測 2022-2027
  • 吸入器 - 市場規模と予測 2022-2027
  • 投与経路別の市場機会

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米 - 市場規模と予測 2022-2027
  • 欧州 - 市場規模と予測 2022-2027
  • アジア - 市場規模と予測 2022-2027
  • その他の地域(ROW) - 市場規模と予測 2022-2027
  • 米国 - 市場規模と予測 2022-2027
  • ドイツ - 市場規模と予測 2022-2027
  • 中国 - 市場規模と予測 2022-2027
  • 英国 - 市場規模と予測 2022-2027
  • インド - 市場規模と予測 2022-2027
  • 地域情勢別の市場機会

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Amgen Inc.
  • Aurobindo Pharma Ltd.
  • Baxter International Inc.
  • Biocon Ltd.
  • Cadila Pharmaceuticals Ltd.
  • Cipla Ltd.
  • Dr Reddys Laboratories Ltd.
  • Fresenius SE and Co. KGaA
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global generic drugs market 2017 - 2021 ($ billion)
  • Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
  • Exhibits20: Historic Market Size - Route of administration Segment 2017 - 2021 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Type - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Type - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Type
  • Exhibits33: Data Table on Comparison by Type
  • Exhibits34: Chart on Small-molecule generics - Market size and forecast 2022-2027 ($ billion)
  • Exhibits35: Data Table on Small-molecule generics - Market size and forecast 2022-2027 ($ billion)
  • Exhibits36: Chart on Small-molecule generics - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Small-molecule generics - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Biosimilars - Market size and forecast 2022-2027 ($ billion)
  • Exhibits39: Data Table on Biosimilars - Market size and forecast 2022-2027 ($ billion)
  • Exhibits40: Chart on Biosimilars - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Biosimilars - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by Type ($ billion)
  • Exhibits43: Chart on Route of Administration - Market share 2022-2027 (%)
  • Exhibits44: Data Table on Route of Administration - Market share 2022-2027 (%)
  • Exhibits45: Chart on Comparison by Route of Administration
  • Exhibits46: Data Table on Comparison by Route of Administration
  • Exhibits47: Chart on Oral - Market size and forecast 2022-2027 ($ billion)
  • Exhibits48: Data Table on Oral - Market size and forecast 2022-2027 ($ billion)
  • Exhibits49: Chart on Oral - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Data Table on Oral - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Chart on Injectables - Market size and forecast 2022-2027 ($ billion)
  • Exhibits52: Data Table on Injectables - Market size and forecast 2022-2027 ($ billion)
  • Exhibits53: Chart on Injectables - Year-over-year growth 2022-2027 (%)
  • Exhibits54: Data Table on Injectables - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Chart on Topical - Market size and forecast 2022-2027 ($ billion)
  • Exhibits56: Data Table on Topical - Market size and forecast 2022-2027 ($ billion)
  • Exhibits57: Chart on Topical - Year-over-year growth 2022-2027 (%)
  • Exhibits58: Data Table on Topical - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Chart on Inhalers - Market size and forecast 2022-2027 ($ billion)
  • Exhibits60: Data Table on Inhalers - Market size and forecast 2022-2027 ($ billion)
  • Exhibits61: Chart on Inhalers - Year-over-year growth 2022-2027 (%)
  • Exhibits62: Data Table on Inhalers - Year-over-year growth 2022-2027 (%)
  • Exhibits63: Market opportunity by Route of Administration ($ billion)
  • Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits65: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits67: Chart on Geographic comparison
  • Exhibits68: Data Table on Geographic comparison
  • Exhibits69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibits70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibits71: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits72: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibits74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibits75: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits77: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibits78: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibits79: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits85: Chart on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibits86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibits87: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits88: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits89: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibits90: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibits91: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits101: Chart on India - Market size and forecast 2022-2027 ($ billion)
  • Exhibits102: Data Table on India - Market size and forecast 2022-2027 ($ billion)
  • Exhibits103: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibits104: Data Table on India - Year-over-year growth 2022-2027 (%)
  • Exhibits105: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits106: Impact of drivers and challenges in 2022 and 2027
  • Exhibits107: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits108: Overview on factors of disruption
  • Exhibits109: Impact of key risks on business
  • Exhibits110: Vendors covered
  • Exhibits111: Matrix on vendor position and classification
  • Exhibits112: Amgen Inc. - Overview
  • Exhibits113: Amgen Inc. - Product / Service
  • Exhibits114: Amgen Inc. - Key offerings
  • Exhibits115: Aurobindo Pharma Ltd. - Overview
  • Exhibits116: Aurobindo Pharma Ltd. - Product / Service
  • Exhibits117: Aurobindo Pharma Ltd. - Key offerings
  • Exhibits118: Baxter International Inc. - Overview
  • Exhibits119: Baxter International Inc. - Business segments
  • Exhibits120: Baxter International Inc. - Key news
  • Exhibits121: Baxter International Inc. - Key offerings
  • Exhibits122: Baxter International Inc. - Segment focus
  • Exhibits123: Biocon Ltd. - Overview
  • Exhibits124: Biocon Ltd. - Business segments
  • Exhibits125: Biocon Ltd. - Key offerings
  • Exhibits126: Biocon Ltd. - Segment focus
  • Exhibits127: Cadila Pharmaceuticals Ltd. - Overview
  • Exhibits128: Cadila Pharmaceuticals Ltd. - Product / Service
  • Exhibits129: Cadila Pharmaceuticals Ltd. - Key offerings
  • Exhibits130: Cipla Ltd. - Overview
  • Exhibits131: Cipla Ltd. - Business segments
  • Exhibits132: Cipla Ltd. - Key news
  • Exhibits133: Cipla Ltd. - Key offerings
  • Exhibits134: Cipla Ltd. - Segment focus
  • Exhibits135: Dr Reddys Laboratories Ltd. - Overview
  • Exhibits136: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibits137: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibits138: Dr Reddys Laboratories Ltd. - Segment focus
  • Exhibits139: Fresenius SE and Co. KGaA - Overview
  • Exhibits140: Fresenius SE and Co. KGaA - Business segments
  • Exhibits141: Fresenius SE and Co. KGaA - Key news
  • Exhibits142: Fresenius SE and Co. KGaA - Key offerings
  • Exhibits143: Fresenius SE and Co. KGaA - Segment focus
  • Exhibits144: Merck and Co. Inc. - Overview
  • Exhibits145: Merck and Co. Inc. - Business segments
  • Exhibits146: Merck and Co. Inc. - Key news
  • Exhibits147: Merck and Co. Inc. - Key offerings
  • Exhibits148: Merck and Co. Inc. - Segment focus
  • Exhibits149: Novartis AG - Overview
  • Exhibits150: Novartis AG - Business segments
  • Exhibits151: Novartis AG - Key offerings
  • Exhibits152: Novartis AG - Segment focus
  • Exhibits153: Pfizer Inc. - Overview
  • Exhibits154: Pfizer Inc. - Product / Service
  • Exhibits155: Pfizer Inc. - Key news
  • Exhibits156: Pfizer Inc. - Key offerings
  • Exhibits157: Sanofi SA - Overview
  • Exhibits158: Sanofi SA - Business segments
  • Exhibits159: Sanofi SA - Key news
  • Exhibits160: Sanofi SA - Key offerings
  • Exhibits161: Sanofi SA - Segment focus
  • Exhibits162: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibits163: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibits164: Sun Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits165: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits166: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits167: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits168: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits169: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits170: Viatris Inc. - Overview
  • Exhibits171: Viatris Inc. - Business segments
  • Exhibits172: Viatris Inc. - Key offerings
  • Exhibits173: Viatris Inc. - Segment focus
  • Exhibits174: Inclusions checklist
  • Exhibits175: Exclusions checklist
  • Exhibits176: Currency conversion rates for US$
  • Exhibits177: Research methodology
  • Exhibits178: Validation techniques employed for market sizing
  • Exhibits179: Information sources
  • Exhibits180: List of abbreviations
目次
Product Code: IRTNTR44584

Technavio has been monitoring the generic drugs market and it is poised to grow by $176.25 bn during 2023-2027, accelerating at a CAGR of 7.11% during the forecast period. Our report on the generic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by low-cost alternatives, increased outsourcing of drug discovery and development, and rising drug patent expirations.

Technavio's generic drugs market is segmented as below:

By Route Of Administration

  • Oral
  • Injectables
  • Topical
  • Inhalers

By Type

  • Small-molecule generics
  • Biosimilars

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the advent of RPA as one of the prime reasons driving the generic drugs market growth during the next few years. Also, rising m and a and hospital-owned generics will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the generic drugs market covers the following areas:

  • Generic drugs market sizing
  • Generic drugs market forecast
  • Generic drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading generic drugs market vendors that include Abbott Laboratories, Amgen Inc., Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sun Pharmaceutical Industries Ltd., Lupin Ltd., Cadila Pharmaceuticals Ltd., and Cipla Ltd. Also, the generic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global generic drugs market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global generic drugs market 2017 - 2021 ($ billion)
  • 4.2 Type Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
  • 4.3 Route of administration Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Route of administration Segment 2017 - 2021 ($ billion)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

  • 6.1 Market segments
  • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
  • 6.2 Comparison by Type
  • Exhibit 32: Chart on Comparison by Type
  • Exhibit 33: Data Table on Comparison by Type
  • 6.3 Small-molecule generics - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Small-molecule generics - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 35: Data Table on Small-molecule generics - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 36: Chart on Small-molecule generics - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Small-molecule generics - Year-over-year growth 2022-2027 (%)
  • 6.4 Biosimilars - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Biosimilars - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 39: Data Table on Biosimilars - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 40: Chart on Biosimilars - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Biosimilars - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Type
  • Exhibit 42: Market opportunity by Type ($ billion)

7 Market Segmentation by Route of Administration

  • 7.1 Market segments
  • Exhibit 43: Chart on Route of Administration - Market share 2022-2027 (%)
  • Exhibit 44: Data Table on Route of Administration - Market share 2022-2027 (%)
  • 7.2 Comparison by Route of Administration
  • Exhibit 45: Chart on Comparison by Route of Administration
  • Exhibit 46: Data Table on Comparison by Route of Administration
  • 7.3 Oral - Market size and forecast 2022-2027
  • Exhibit 47: Chart on Oral - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 48: Data Table on Oral - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 49: Chart on Oral - Year-over-year growth 2022-2027 (%)
  • Exhibit 50: Data Table on Oral - Year-over-year growth 2022-2027 (%)
  • 7.4 Injectables - Market size and forecast 2022-2027
  • Exhibit 51: Chart on Injectables - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 52: Data Table on Injectables - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 53: Chart on Injectables - Year-over-year growth 2022-2027 (%)
  • Exhibit 54: Data Table on Injectables - Year-over-year growth 2022-2027 (%)
  • 7.5 Topical - Market size and forecast 2022-2027
  • Exhibit 55: Chart on Topical - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 56: Data Table on Topical - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 57: Chart on Topical - Year-over-year growth 2022-2027 (%)
  • Exhibit 58: Data Table on Topical - Year-over-year growth 2022-2027 (%)
  • 7.6 Inhalers - Market size and forecast 2022-2027
  • Exhibit 59: Chart on Inhalers - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 60: Data Table on Inhalers - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 61: Chart on Inhalers - Year-over-year growth 2022-2027 (%)
  • Exhibit 62: Data Table on Inhalers - Year-over-year growth 2022-2027 (%)
  • 7.7 Market opportunity by Route of Administration
  • Exhibit 63: Market opportunity by Route of Administration ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 67: Chart on Geographic comparison
  • Exhibit 68: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 China - Market size and forecast 2022-2027
  • Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.10 UK - Market size and forecast 2022-2027
  • Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.11 India - Market size and forecast 2022-2027
  • Exhibit 101: Chart on India - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 102: Data Table on India - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 103: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibit 104: Data Table on India - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 105: Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 106: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 108: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 109: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 110: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 111: Matrix on vendor position and classification
  • 12.3 Amgen Inc.
  • Exhibit 112: Amgen Inc. - Overview
  • Exhibit 113: Amgen Inc. - Product / Service
  • Exhibit 114: Amgen Inc. - Key offerings
  • 12.4 Aurobindo Pharma Ltd.
  • Exhibit 115: Aurobindo Pharma Ltd. - Overview
  • Exhibit 116: Aurobindo Pharma Ltd. - Product / Service
  • Exhibit 117: Aurobindo Pharma Ltd. - Key offerings
  • 12.5 Baxter International Inc.
  • Exhibit 118: Baxter International Inc. - Overview
  • Exhibit 119: Baxter International Inc. - Business segments
  • Exhibit 120: Baxter International Inc. - Key news
  • Exhibit 121: Baxter International Inc. - Key offerings
  • Exhibit 122: Baxter International Inc. - Segment focus
  • 12.6 Biocon Ltd.
  • Exhibit 123: Biocon Ltd. - Overview
  • Exhibit 124: Biocon Ltd. - Business segments
  • Exhibit 125: Biocon Ltd. - Key offerings
  • Exhibit 126: Biocon Ltd. - Segment focus
  • 12.7 Cadila Pharmaceuticals Ltd.
  • Exhibit 127: Cadila Pharmaceuticals Ltd. - Overview
  • Exhibit 128: Cadila Pharmaceuticals Ltd. - Product / Service
  • Exhibit 129: Cadila Pharmaceuticals Ltd. - Key offerings
  • 12.8 Cipla Ltd.
  • Exhibit 130: Cipla Ltd. - Overview
  • Exhibit 131: Cipla Ltd. - Business segments
  • Exhibit 132: Cipla Ltd. - Key news
  • Exhibit 133: Cipla Ltd. - Key offerings
  • Exhibit 134: Cipla Ltd. - Segment focus
  • 12.9 Dr Reddys Laboratories Ltd.
  • Exhibit 135: Dr Reddys Laboratories Ltd. - Overview
  • Exhibit 136: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibit 137: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibit 138: Dr Reddys Laboratories Ltd. - Segment focus
  • 12.10 Fresenius SE and Co. KGaA
  • Exhibit 139: Fresenius SE and Co. KGaA - Overview
  • Exhibit 140: Fresenius SE and Co. KGaA - Business segments
  • Exhibit 141: Fresenius SE and Co. KGaA - Key news
  • Exhibit 142: Fresenius SE and Co. KGaA - Key offerings
  • Exhibit 143: Fresenius SE and Co. KGaA - Segment focus
  • 12.11 Merck and Co. Inc.
  • Exhibit 144: Merck and Co. Inc. - Overview
  • Exhibit 145: Merck and Co. Inc. - Business segments
  • Exhibit 146: Merck and Co. Inc. - Key news
  • Exhibit 147: Merck and Co. Inc. - Key offerings
  • Exhibit 148: Merck and Co. Inc. - Segment focus
  • 12.12 Novartis AG
  • Exhibit 149: Novartis AG - Overview
  • Exhibit 150: Novartis AG - Business segments
  • Exhibit 151: Novartis AG - Key offerings
  • Exhibit 152: Novartis AG - Segment focus
  • 12.13 Pfizer Inc.
  • Exhibit 153: Pfizer Inc. - Overview
  • Exhibit 154: Pfizer Inc. - Product / Service
  • Exhibit 155: Pfizer Inc. - Key news
  • Exhibit 156: Pfizer Inc. - Key offerings
  • 12.14 Sanofi SA
  • Exhibit 157: Sanofi SA - Overview
  • Exhibit 158: Sanofi SA - Business segments
  • Exhibit 159: Sanofi SA - Key news
  • Exhibit 160: Sanofi SA - Key offerings
  • Exhibit 161: Sanofi SA - Segment focus
  • 12.15 Sun Pharmaceutical Industries Ltd.
  • Exhibit 162: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibit 163: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibit 164: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 12.16 Teva Pharmaceutical Industries Ltd.
  • Exhibit 165: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 166: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 168: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 169: Teva Pharmaceutical Industries Ltd. - Segment focus
  • 12.17 Viatris Inc.
  • Exhibit 170: Viatris Inc. - Overview
  • Exhibit 171: Viatris Inc. - Business segments
  • Exhibit 172: Viatris Inc. - Key offerings
  • Exhibit 173: Viatris Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 174: Inclusions checklist
  • Exhibit 175: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 176: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 177: Research methodology
  • Exhibit 178: Validation techniques employed for market sizing
  • Exhibit 179: Information sources
  • 13.5 List of abbreviations
  • Exhibit 180: List of abbreviations